LMP2A-Specific Cytotoxic T-Lymphocytes

A preparation of cytotoxic T-lymphocytes (CTL), specifically reactive to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP2A), with potential antineoplastic activity. T-lymphocytes are exposed ex vivo to dendritic cells (DCs) transfected with a replication-deficient adenovirus encoding EBV LMP2A. Subsequently, LMP2A-specific CTLs are exposed to EBV infected cells transfected with adenovirus encoding LMP2A, thereby further stimulating CTLs. Administered to patients with EBV-positive tumors, LMP2A-specific CTLs target LMP2A-positive cells, resulting in cell lysis and inhibition of cancer cell proliferation. EBV LMP2A may be expressed in various malignancies, including nasopharyngeal carcinoma and Hodgkin and non-Hodgkin lymphomas. (NCI Thesaurus)

YOU MAY ALSO LIKE

LMP-2:419-427 Peptide Vaccine

A peptide vaccine containing amino acids residues from 419 through 427 of the latent membrane protein-2 (LMP-2) of the Epstein-Barr virus (EBV)…

LMP-2:340-349 Peptide Vaccine

A peptide vaccine containing amino acids residues from 340 through 349 of the latent membrane protein-2 (LMP-2) of the Epstein-Barr virus (EBV)…

LMO2 wt Allele

Human LMO2 wild-type allele is located in the vicinity of 11p13 and is approximately 34 kb in length. This allele, which encodes…

LMO2 Gene

This gene plays a crucial role in hematopoietic development and is involved in transcriptional activation.

LMO1 wt Allele

Human LMO1 wild-type allele is located in the vicinity of 11p15 and is approximately 44 kb in length. This allele, which encodes…

LMO1 Gene

This gene is involved in the regulation of transcription.